Effect of Dorzolamide/Timolol or Brinzolamide/Timolol Prophylaxis on Intravitreal Anti-VEGF Injection-Induced Intraocular Hypertension

REFERENCES

• Lee YJ, Park HJ, Lee TG, et al. Primary combined photodynamic therapy and intravitreal bevacizumab injection for neovascular age-related macular degeneration. J Korean Ophthalmol Soc 2010;051:35–41
   Google Scholar
• Smit DP, Meyer D. Intravitreal bevacizumab: An analysis of the evidence. Clin Ophthalmology 2007;1:273–284
   Google Scholar
• Matri L, Chebil A, Kort F, et al. Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2010;248:779–784
   Google Scholar
• Sampat KM, Garg SJ. Complications of intravitreal injections. Curr Opin Ophthalmol 2010;21:178–183
   PubMed Web of Science ®Google Scholar
• Nunes RP, Nóbrega MJ, De Novelli FJ, et al. Causes of interruption of bevacizumab therapy in age-related macular degeneration. Arq Bras Oftalmol 2010;73:146–149
   Google Scholar
• Park HY, Yi KY, Kim HK. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Korean J Ophthalmol 2005;19:122–127
   PubMedGoogle Scholar
• Ziad FB, Abdallah MT, Christelle PE, et al. Intravitreal triamcinolone acetonide: pattern of secondary intraocular pressure rise and possible risk factors. Clin Ophthalmol 2008;2:269–274
   Google Scholar
• Pong JC. Anterior chamber paracentesis in patients with acute elevation of intraocular pressure. Graefes Arch Clin Exp Ophthalmol 2008;246:463–464
   Google Scholar
• Arnavielle S, Creuzot-Garcher C, Bron AM. Anterior chamber paracentesis in patients with acute elevation of intraocular pressure. Graefes Arch Clin Exp Ophthalmol 2007;245:345–350
   Google Scholar
• Cheung MG, Durrani OG, Murray PI. The safety of anterior chamber paracentesis in patients with uveitis. Br J Ophthalmol 2004;88:582–583
   Web of Science ®Google Scholar
• Lee SJ, Lee JJ, Kim SD. Multiple retinal hemorrhage following anterior chamber paracentesis in uveitic glaucoma. Korean J Ophthalmol 2006;20:128–130
   Google Scholar
• Astam N, Batioglu F, Ozmert E. Short-term efficacy of intravitreal bevacizumab for the treatment of macular edema due to diabetic retinopathy and retinal vein occlusion. Int Ophthalmol 2009;29:543–548
   Google Scholar
• Avery RI, Pearlman, J Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695
   PubMed Web of Science ®Google Scholar
• Atchaneeyasakul LO, Trinavarat A. Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity. J Perinatol 2010;30:497–499
   PubMedGoogle Scholar
• Brouzas D, Koutsandrea C, Moschos M, et al. Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin) for AMD followed by controlateral sympathetic ophthalmia. Clin Ophthalmol 2009;3:457–459
   PubMedGoogle Scholar
• Artunay O, Yuzbasioglu E, Rasier R, et al. Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection. Eye (Lond) 2009;23:2187–2193
   Google Scholar
• Sharei V, Hohn F, Kohler T, et al. Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis). Eur J Ophthalmol 2010;20:174–179
   PubMed Web of Science ®Google Scholar
• Adelman R, Zheng Q, Mayer HR. Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections. J Ocul Pharmacol Ther 2010;26:105–110
   PubMed Web of Science ®Google Scholar
• Chang W, Chung M. Efficacy of anterior chamber paracentesis in intravitreal tramcinolone injection. Eur J Ophthalmol 2007;17:776–779
   Google Scholar
• Seong HK, Lee JM, Park YS, et al. Immediate national course of IOP after IVTA and the effect of preoperative ocular massage. J Korean Ophthalmol Soc 2007;48:808–814
   Google Scholar
• Theoulakis PE, Lepidas J, Petropoulos IK, et al. Effect of brimonidine/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab. Klin Monbi Augenheilkd 2010;227:280–284
   Google Scholar
• Maurizio G, Carlo S, Maria, S, et al. Short-term effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure. J Glaucoma 2009;18:658–661
   Google Scholar
• Shonat RD, Wilson DF, Riva CE, et al. Effect of acute increase in intraocular pressure on intravascular optic nerve head-oxygen tension in cats. Investigative Ophthalmol Vis Sci 1992;33:3174–3180
   PubMedGoogle Scholar
• Calugaru D, Calugaru M. Fixed combinations of glaucoma medications. Oftalmologia 2008;52:23–31
   Google Scholar
• Yeh J, Kravitz D, Francis B. Rational use of the fixed combination of dorzolamide - timolol in the management of raised intraocular pressure and glaucoma. Clin Ophthalmol 2008;2:389–399
   PubMedGoogle Scholar
• Shim JC, Choe CM, Seong GJ. A comparision of short term use effects and safety of timoptic with those of cosopt in normal Korean. J Korean Ophthalmol Soc 2002;43:1206–1211
   Google Scholar
• Miglior S, Grunden JW, Kwok K. Efficacy and safety of fixed combinations of latanoprost/timolol and dorzolamide/timolol in open-angle glaucoma or ocular hypertension. Eye 2010;24:1234–1242
   PubMed Web of Science ®Google Scholar
• Miguel AT, Stefano M, Guna L, et al. Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension. Clin Ophthalmol 2009;3:629–636
   Google Scholar
• Eakins KE, Whitelocke RAF, Bennett A, Martenet AC. Prostaglandin-like activity in ocular inflammation. Br Med J 1972;3:452
   PubMed Web of Science ®Google Scholar
• Jampol LM. Aphakic cystoids macular edema: a hypothesis. Arch Ophthalmol 1985;103:1134–1135
   Google Scholar